Mendeleev Commun., 2012, 22, 181–183
Table 1 Formation of 4-arylcyclopentane-1,1,3,3-tetracarboxylates 4 in
when other nitrogen-containing compounds (azobenzene, pyridine,
or triethylamine) were used in place of pyrazoline 3. The reaction
using other 1-pyrazolines containing a hydrogen atom in the
a-position with respect to the N=N bond occurred by the path-
ways described previously1 without fragmentation of the starting
reactants. Thus, the system comprising 1-pyrazoline 3 and GaCl3
proved to be specific, ensuring the formation of compounds 4 and 5.
Note that both the individual E- and Z-isomers of pyrazoline 3
or their mixture (~3.5:1) prepared by 1,3-dipolar cycloaddition
of methyl diazopropionate to methyl methacrylate6 were equally
efficient in the reaction.
The discovered method for synthesizing cyclopentanetetra-
carboxylate 4a from 1a is well reproducible for other 2-arylcyclo-
propane-1,1-dicarboxylates 1b–j (Table 1).† The reactions with
cyclopropanes 1b–d containing halogen atoms in the ortho- and
meta-positions of the benzene ring occurred most readily. Similar
reactions proceeded with naphthyl-substituted substrates 1i,j. All
the 4-arylcyclopentane-1,1,3,3-tetracarboxylates 4a–j obtained
manifest a characteristic upfield shift of protons of one of the
methoxy groups (dH 3.13–3.27, and even higher, viz., 2.83 and
3.03, for naphthyl-substituted derivatives 4i,j). This arrangement
of signals is typical of the cis-CO2Me group at C3, which is located
above the plane of the adjacent benzene ring within its ‘negative
cone’ of anisotropy.
the GaCl3-catalyzed reaction of 2-arylcyclopropane-1,1-dicarboxylates 1
with pyrazoline E-3.a
Entry
Reagent
Ar
Product
Yield (%)b
1
2
3
4
5
6
7
8
9
1a
1b
1c
1d
1e
1f
1g
1h
1i
Ph
4a
4b
4c
4d
4e
4f
4g
4h
4i
60
91
86
80
57
68
69
65
50
48
2-ClC6H4
3-ClC6H4
3-BrC6H4
4-MeC6H4
4-FC6H4
4-ClC6H4
4-BrC6H4
1-naphthyl
2-naphthyl
10
1j
4j
a Reaction conditions: 1:3:GaCl3 = 1:0.5:0.3, CH2Cl2, sealed tube, 80°C,
3 h. The optimum time and temperature were determined by NMR monitoring
the reaction in an NMR tube. b Isolated yields.
The proposed mechanism of this process is outlined in
Scheme 3. First, cyclopropanedicarboxylate 1 on contact with
gallium trichloride is opened to give bipolar intermediate I, which
adds to a molecule of pyrazoline 2 to produce intermediate II.
No migration of substituents at the heterocycle can occur in
intermediate II, so it adds a second molecule 1 to form bipolar
intermediate III. Intramolecular SN2 attack by a malonyl anion
on the sterically free CH2 group in III results in splitting of
the latter to afford cyclopentane 4 and azomethineimine 5. The
nucleophilic attack occurs on the methylene group, whereas attack
on the methine C atom appears unlike due to considerable steric
hindrance. The resulting azomethine 5 is unstable under acidic
conditions and is hydrolyzed during the workup of the reaction
mixture to give pyrazolidine 6 and the corresponding benz-
aldehydes 7.
Note that cyclopentanes 4 cannot be obtained by direct [2+3]-
cycloaddition of cyclopropanedicarboxylates 1 to methylidene-
malonate, since donor-acceptor cyclopropanes readily add to
electron-rich double bonds,7 but do not react with electron-
deficient ones. In this study, we suggested a ‘bypass’ route for
synthesizing cyclopentanes 4 by oxidative doubling of readily
available cyclopropanedicarboxylates 1. During the doubling
of cyclopropanedicarboxylates, the second molecule of cyclo-
propane 1 is synthetically equivalent to methylidenemalonate.
In summary, we have discovered a new unusual reaction of
2-arylcyclopropane-1,1-dicarboxylates with a 3,3,5,5-tetrasub-
stituted 1-pyrazoline in the presence of catalytic amounts of
GaCl3 to give 4-arylcyclopentane-1,1,3,3-tetracarboxylates in
high yields. In this case, 1-pyrazoline acts as the oxidant, causing
Tetramethyl 4-(2-chlorophenyl)cyclopentane-1,1,3,3-tetracarboxylate
4b.Yield, 91%. IR (CHCl3, n/cm–1): 3020, 2976, 1956, 2896, 2846, 1734
1
(br., O=CO), 1521, 1479, 1436, 1393, 1256. H NMR, d: 2.67 (dd, 1H,
Ha-5, 2J 14.0 Hz, 3J 10.4 Hz), 2.89 (ddd, 1H, Hb-5, 2J 14.0 Hz, 3J 8.1 Hz,
4J 1.3 Hz), 3.05 (dd, 1H, Ha-2, 2J 14.5 Hz, 4J 1.3 Hz), 3.27 (s, 3H, C3O2Me),
3.28 (d, 1H, Hb-2, 2J 14.5 Hz), 3.73, 3.76 and 3.78 (all s, 3×3H, 3OMe),
4.83 (dd, 1H, H-4, 3J 10.4 and 8.1 Hz), 7.14 (ddd, 1H, C6H4, 3J 7.8 and
7.6 Hz, 4J1.6 Hz), 7.19 (ddd, 1H, C6H4, 3J7.7 and 7.6 Hz, 4J 1.5 Hz), 7.27 (dd,
1H, C6H4, 3J 7.7 Hz, 4J 1.6 Hz), 7.35 (dd, 1H, C6H4, 3J 7.8 Hz, 4J 1.5 Hz).
13C NMR, d: 40.9 (C5H2), 41.9 (C2H2), 45.0 (C4H), 52.3, 53.1 and 53.2
(1C, 1C and 2C, 4OMe), 58.9 (C1), 64.9 (C3), 126.7, 128.4, 129.2 and 129.7
(4CH, C6H4), 135.3 (CCl), 137.5 (i-C), 169.9, 171.2, 171.4 and 171.6
(4COO). MS, m/z (%): 377 (11), 317 (24), 261 (11), 257 (10), 155 (13),
149 (11), 115 (20), 113 (24), 103 (7), 89 (7), 77 (8), 59 (100). HRMS,
m/z: 435.0809 (calc. for C19H2135ClO8, m/z: 435.0817 [M+Na]+).
Tetramethyl 4-(3-chlorophenyl)cyclopentane-1,1,3,3-tetracarboxylate
4c. Yield, 86%. 1H NMR, d: 2.58 (ddd, 1H, Ha-5, 2J 13.5 Hz, 3J 6.8 Hz,
4J 1.6 Hz), 2.80 (dd, 1H, Hb-5, 2J 13.5 Hz, 3J 13.1 Hz), 2.96 (dd, 1H, Ha-2,
2J 14.5 Hz, 4J 1.6 Hz), 3.13 (s, 3H, C3O2Me), 3.16 (d, 1H, Hb-2, 2J 14.5 Hz),
3.75, 3.76 and 3.79 (all s, 3×3H, 3OMe), 4.07 (dd, 1H, H-4, 3J 13.1 and
6.8 Hz), 7.17–7.24 (m, 3H, C6H4), 7.31 (m, 1H, H2', C6H4). 13C NMR, d:
38.7 (C5H2), 41.4 (C2H2), 48.9 (C4H), 52.4, 53.0, 53.1 and 53.2 (4OMe),
58.6 (C1), 64.5 (C3), 127.0, 127.7, 128.8 and 129.3 (4CH, C6H4), 134.0
(CCl), 140.2 (i-C), 170.3, 170.9, 171.6 and 171.9 (4COO). MS, m/z (%):
414 (2) and 412 (5) [M]+, 383 (1) and 381 (3) [M–OMe]+, 354 (6) and
352 (16) [M–HCO2Me]+, 349 (7), 322 (18), 321 (11), 320 (54), 292 (19),
263 (18), 262 (11), 261 (64), 260 (8), 233 (24), 205 (12), 175 (17), 155
(17), 149 (18), 141 (16), 139 (32), 115 (27), 113 (30), 71 (25), 59 (100).
HRMS, m/z: 435.0809 (calc. for C19H2135ClO8, m/z: 435.0817 [M+Na]+).
Tetramethyl 4-(4-fluorophenyl)cyclopentane-1,1,3,3-tetracarboxylate
4f. Yield, 68%. IR (CHCl3, n/cm–1): 3020, 2956, 2928, 2853, 1733 (br.,
O=CO), 1686, 1654, 1646, 1602, 1513, 1474, 1436, 1347, 1263, 1223.
1H NMR, d: 2.58 (ddd, 1H, Ha-5, 2J 13.4 Hz, 3J 6.7 Hz, 4J 1.6 Hz), 2.81
Tetramethyl 4-(1-naphthyl)cyclopentane-1,1,3,3-tetracarboxylate 4i.
Yield, 50%. IR (CHCl3, n/cm–1): 3023, 2955, 1732 (br., O=CO), 1599,
1515, 1435, 1255, 1227. 1H NMR, d: 2.83 (s, 3H, C3O2Me), 2.85 (dd, 1H,
Ha-5, 2J 13.7 Hz, 3J 10.7 Hz), 2.92 (ddd, 1H, Hb-5, 2J 13.7 Hz, 3J 7.9 Hz,
4J 1.6 Hz), 3.08 (dd, 1H, Ha-2, 2J 14.4 Hz, 4J 1.6 Hz), 3.40 (d, 1H, Hb-2,
2J 14.4 Hz), 3.72, 3.80 and 3.81 (all s, 3×3H, 3OMe), 5.21 (dd, 1H,
H-4, 3J 10.7 and 7.9 Hz), 7.36–7.44 (m, 2H, 1-naphthyl), 7.46 (ddd, 1H,
1-naphthyl, 3J 8.0 and 6.9 Hz, 4J 1.0 Hz), 7.55 (ddd, 1H, 1-naphthyl, 3J 8.5
and 6.8 Hz, 4J 1.4 Hz), 7.72 (br.dd, 1H, 1-naphthyl, 3J 6.9 Hz, 4J 2.2 Hz),
7.81 (br.d, 1H, 1-naphthyl, 3J 8.1 Hz), 8.50 (br.d, 1H, 1-naphthyl, 3J 8.6 Hz).
13C NMR, d: 41.7, 42.0 and 43.0 (C5H2, C2H2 and C4H), 52.0, 53.17 and
53.23 (1C, 1C and 2C, 4OMe), 59.4 (C1), 65.5 (C3), 124.5, 125.1, 125.4,
125.7, 126.2, 128.1 and 128.7 (7CH, 1-naphthyl), 132.7, 133.9 and 136.2
(3C, 1-naphthyl), 170.0, 171.3, 171.8 and 172.2 (4COO). MS, m/z (%):
428 (13) [M]+, 397 (0.1) [M–OMe]+, 368 (3) [M–HCO2Me]+, 337 (10),
277 (31), 224 (22), 220 (19), 219 (19), 217 (31), 189 (66), 179 (21), 165
(100), 152 (34), 145 (20), 128 (15), 113 (25), 59 (97). HRMS, m/z: 451.1346
(calc. for C23H24O8, m/z: 451.1346 [M+Na]+).
2
3
2
(dd, 1H, Hb-5, J 13.4 Hz, J 13.2 Hz), 2.97 (dd, 1H, Ha-2, J 14.5 Hz,
4J 1.6 Hz), 3.15 (d, 1H, Hb-2, 2J 14.5 Hz), 3.20, 3.75, 3.76 and 3.80 (all s,
4×3H, 4OMe), 4.10 (dd, 1H, H-4, J 13.2 and 6.7 Hz), 6.95 (m, 2H,
3
2m-CH, 3JHF 8.7 Hz), 7.31 (m, 2H, 2o-CH, 4JHF 5.5 Hz). 13C NMR, d: 38.8
(C5H2), 41.4 (C2H2), 48.5 (C4H), 52.3, 52.9, 53.1 and 53.2 (4OMe), 58.7
(C1), 64.5 (C3), 114.9 (2m-CH, 2JCF 21.2 Hz), 130.3 (2o-CH, 3JCF 7.9 Hz),
133.7 (i-C, 4JCF 3.3 Hz), 162.2 (p-CF, 1JCF 246 Hz), 170.4, 171.0, 171.8
and 172.0 (4COO). 19F NMR, d: –116.0 (tt, 1F, 3JHF 8.7 Hz, 4JHF 5.5 Hz).
MS, m/z(%): 396 (0.2) [M]+, 365 (0.2) [M–OMe]+, 336 (6) [M–HCO2Me]+,
304 (18), 276 (8), 245 (25), 217 (19), 159 (15), 133 (25), 123 (35), 113 (14),
95 (14), 59 (100). HRMS, m/z: 419.1104, 435.0848 (calc. for C19H21FO8,
m/z: 419.1113 [M+Na]+, 435.0852 [M+K]+).
For characteristics of compounds 4d,e,g,h,j, see Online Supplementary
Materials.
– 182 –